4-n-bis(2-chloroethyl)aminobenzoylglutamic acid has been researched along with Choriocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoniw, P; Bagshawe, KD; Burke, PJ; Melton, RG; Rogers, GT; Searle, F; Sherwood, RF; Springer, CJ | 1 |
| Antoniw, P; Bagshawe, KD; Melton, RG; Searle, F; Sharma, SK; Sherwood, RF; Springer, CJ | 1 |
2 other study(ies) available for 4-n-bis(2-chloroethyl)aminobenzoylglutamic acid and Choriocarcinoma
| Article | Year |
|---|---|
Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice.
Topics: Animals; Biotransformation; Choriocarcinoma; Colonic Neoplasms; gamma-Glutamyl Hydrolase; Glutamates; Humans; Mice; Neoplasm Transplantation; Nitrogen Mustard Compounds; Prodrugs; Transplantation, Heterologous | 1990 |
A cytotoxic agent can be generated selectively at cancer sites.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carboxypeptidases; Cell Line; Choriocarcinoma; Glutamates; Humans; Mice; Mice, Nude; Nitrogen Mustard Compounds; para-Aminobenzoates; Prodrugs | 1988 |